Published in Heart Fail Rev on July 01, 2011
Coronary artery disease detection - limitations of stress testing in left ventricular dysfunction. World J Cardiol (2017) 0.75
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25
Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol (2005) 6.07
Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol (2005) 5.99
Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation (2006) 4.98
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation (2003) 4.48
ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol (2007) 4.12
Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol (2006) 4.10
A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol (2002) 3.97
Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation (1998) 3.68
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol (2010) 3.29
Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2000) 2.85
64-slice CT for diagnosis of coronary artery disease: a systematic review. Am J Med (2008) 2.57
Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation (2004) 2.50
Right ventricular infarction. N Engl J Med (1994) 2.48
Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol (2007) 2.45
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation (2010) 2.41
The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol (2009) 2.41
Navigating the crossroads of coronary artery disease and heart failure. Circulation (2006) 2.06
Cardiac positron emission tomography. J Am Coll Cardiol (2009) 1.96
Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging (2009) 1.93
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol (2002) 1.68
American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol (2000) 1.64
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol (1997) 1.62
Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy. J Am Coll Cardiol (2007) 1.55
Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. J Am Coll Cardiol (1998) 1.51
Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction. Am Heart J (2002) 1.48
Sixty-four-slice multidetector computed tomography: an accurate imaging modality for the evaluation of coronary arteries in dilated cardiomyopathy of unknown etiology. Circ Cardiovasc Imaging (2009) 1.45
Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol (1993) 1.43
Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol (2003) 1.43
Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol (2007) 1.36
Computed tomography coronary angiography. J Am Coll Cardiol (2006) 1.30
Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol (2005) 1.27
Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging. JACC Cardiovasc Imaging (2009) 1.18
Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging. Magn Reson Med (2003) 1.12
Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol (2006) 1.09
Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events. Am J Cardiol (2003) 1.05
Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. Eur Heart J (1993) 1.01
Integration of coronary anatomy and myocardial perfusion imaging. Nat Rev Cardiol (2010) 1.00
Determinants of hemodynamic compromise with severe right ventricular infarction. Circulation (1990) 0.99
Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement. Am Heart J (2006) 0.98
Cardiac imaging in coronary artery disease: differing modalities. Heart (2005) 0.97
Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. Heart Fail Clin (2009) 0.96
Assessment of diastolic function by cardiovascular magnetic resonance. Am Heart J (2002) 0.95
Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET. Eur J Nucl Med Mol Imaging (2006) 0.94
Nephrogenic systemic fibrosis: history and epidemiology. Radiol Clin North Am (2009) 0.93
Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure. Eur J Echocardiogr (2009) 0.90
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned? J Magn Reson Imaging (2009) 0.89
Comparison of thallium-201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Circulation (1982) 0.88
Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure. Circulation (2005) 0.86
Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J (2008) 0.84
Thallium 201 imaging and gated cardiac blood pool scans in patients with ischemic and idiopathic congestive cardiomyopathy. A clinical and pathologic study. Circulation (1977) 0.83
Assessment of ventricular function with cardiovascular magnetic resonance. Cardiol Clin (2007) 0.83
Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography. Am J Cardiol (1987) 0.81
Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease. Am J Cardiol (2003) 0.81
Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol (1991) 0.81
Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol (1994) 0.81
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging (2005) 0.81
Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. J Nucl Med (1993) 0.80
Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. Arch Intern Med (1992) 0.78
Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: comparison of idiopathic dilated cardiomyopathy and coronary artery disease. Am J Cardiol (1985) 0.78
Accuracy of 16-detector multislice spiral computed tomography in the initial evaluation of dilated cardiomyopathy. Eur J Radiol (2006) 0.77
Contrast echocardiography: over-achievement in research, under-achievement in practice? JACC Cardiovasc Imaging (2010) 0.77
Tomographic coronary angiography by EBCT and MDCT. Prog Cardiovasc Dis (2003) 0.76
Usefulness of dipyridamole-thallium-201 perfusion scanning for distinguishing ischemic from nonischemic cardiomyopathy. Am J Cardiol (1988) 0.76
Cardiovascular magnetic resonance imaging. Clin Cardiol (2006) 0.76
Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy. Chin Med J (Engl) (2000) 0.75
Dual-source computed tomographic temporal resolution provides higher image quality than 64-detector temporal resolution at low heart rates. J Comput Assist Tomogr (2010) 0.75
Visualizing the coronaries in patients presenting with heart failure of unknown etiology. J Am Coll Cardiol (2007) 0.75
Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction. Cardiol J (2009) 1.45
Coronary computed tomography angiography in dialysis patients undergoing pre-renal transplantation cardiac risk stratification. Cardiol J (2010) 1.39
Feature tracking measurement of dyssynchrony from cardiovascular magnetic resonance cine acquisitions: comparison with echocardiographic speckle tracking. J Cardiovasc Magn Reson (2013) 1.00
Augmentation strategies for treatment-resistant depression. Curr Opin Psychiatry (2009) 0.85
Daily iron supplementation is more efficacious than twice weekly iron supplementation for the treatment of childhood anemia in western Kenya. J Nutr (2004) 0.84
The Importance of Invasive Hemodynamics for Pulmonary Hypertension Screening in TAVR Patients. J Am Coll Cardiol (2017) 0.75
Imaging for structural heart procedures: focus on computed tomography. EuroIntervention (2017) 0.75
From headache to heartache: ergotamine-induced aortic and mitral valvulopathy. J Am Coll Cardiol (2013) 0.75